- Report
- October 2022
- 73 Pages
United States
From €1100EUR$1,186USD£947GBP
- Report
- January 2022
- 52 Pages
Europe
From €1100EUR$1,186USD£947GBP
- Report
- February 2019
- 55 Pages
Global
From €1050EUR$1,132USD£904GBP
- Report
- September 2024
- 73 Pages
Canada
From €924EUR$930USD£768GBP
- Report
- August 2024
- 223 Pages
China
From €3974EUR$4,000USD£3,304GBP
- Report
- March 2024
- 18 Pages
Australia
From €780EUR$785USD£648GBP
- Report
- July 2023
- 224 Pages
Global
From €3800EUR$3,825USD£3,159GBP
€4471EUR$4,500USD£3,717GBP
- Report
- July 2023
- 222 Pages
Global
From €3800EUR$3,825USD£3,159GBP
€4471EUR$4,500USD£3,717GBP
- Report
- February 2022
- 151 Pages
South Africa
From €2484EUR$2,500USD£2,065GBP
- Report
- January 2022
- 60 Pages
Global
From €2747EUR$2,765USD£2,284GBP
€3924EUR$3,950USD£3,263GBP
- Report
- December 2020
- 200 Pages
Global
€4421EUR$4,450USD£3,676GBP
- Book
- April 2019
- 836 Pages
Canada
- Training
- 2 Hours
Global
- Training
- 120 Minutes
Global
- Training
- 60 Minutes
Global
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
- Drug Pipelines
- January 2022
- 30 Pages
Global
From €348EUR$350USD£289GBP
€497EUR$500USD£413GBP
The Analgesics market is a sector of the pharmaceutical industry that focuses on the production and sale of drugs used to relieve pain. Analgesics are used to treat a variety of conditions, including headaches, muscle pain, arthritis, and post-operative pain. Common analgesics include non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and acetaminophen.
Analgesics are available in a variety of forms, including tablets, capsules, liquids, and topical creams. Many analgesics are available over-the-counter, while others require a prescription.
The analgesics market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the analgesics market include Pfizer, Johnson & Johnson, GlaxoSmithKline, Novartis, and Merck. Show Less Read more